person · Reporting owner
HARRISON WILLIAM B JR
Disclosed activity across 3 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Merck & Co., Inc.MRK · Entity 2807 | Director | April 13, 2016 | April 13, 2016 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Merck & Co., Inc.
Report date April 13, 2016 · Filed April 13, 2016
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 16,400 |
Reported balance
After 2016-04-13 transaction · row 1
1 source rowRow 1 · 2016-04-13 · Exercise / conversion · Acquired 5,000 · Balance 16,400 |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $34.44 · Expires 2016-04-27 | Direct | 0 |
Reported balance
After 2016-04-13 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2016-04-13 · Exercise / conversion · Disposed 5,000 · Balance 0 F1: The option became exercisable in equal installments on 4/28/2007, 4/28/2008 and 4/28/2009. |
Filing footnotes · ownership attribution and instrument terms
F1: The option became exercisable in equal installments on 4/28/2007, 4/28/2008 and 4/28/2009.
Past disclosures · reporting ended (2)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Cadence Bancorporation
Report date October 29, 2021 · Filed October 29, 2021
Section 16 reporting ended · disclosed 2021-10-29. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common Stock, par value $0.01 per shareSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2021-10-29 transaction · row 1
1 source rowRow 1 · 2021-10-29 · Disposition to issuer · Disposed 120,102 · Balance 0 F1: Disposed of in connection with the Agreement and Plan of Merger by and between BancorpSouth Bank ("BXS") and Cadence Bancorporation ("Cadence"), dated April 12, 2021 and amended as of May of 27, 2021 (the "Merger Agreement"), pursuant to which Cadence was merged with and into BXS, effective October 29, 2021 (the "Merger"). Pursuant to the Merger, each issued and outstanding share of Cadence common stock par value $0.01 was converted into the right to receive .70 shares of the BXS's common stock par value $2.50 per share ("the Exchange Ratio"), subject to cash in lieu of fractional shares. The opening price of the BXS's common stock on the New York Stock Exchange on the effective date of the Merger was $29.16. As a result of the Merger, the reporting person no longer beneficially owns, directly or indirectly, any shares of Cadence common stock. |
| Class A Common Stock, par value $0.01 per shareSEC Table I · non-derivative | IndirectSee Footnote | 0 |
Reported balance
After 2021-10-29 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2021-10-29 · Disposition to issuer · Disposed 571,961 · Balance 0 F1: Disposed of in connection with the Agreement and Plan of Merger by and between BancorpSouth Bank ("BXS") and Cadence Bancorporation ("Cadence"), dated April 12, 2021 and amended as of May of 27, 2021 (the "Merger Agreement"), pursuant to which Cadence was merged with and into BXS, effective October 29, 2021 (the "Merger"). Pursuant to the Merger, each issued and outstanding share of Cadence common stock par value $0.01 was converted into the right to receive .70 shares of the BXS's common stock par value $2.50 per share ("the Exchange Ratio"), subject to cash in lieu of fractional shares. The opening price of the BXS's common stock on the New York Stock Exchange on the effective date of the Merger was $29.16. As a result of the Merger, the reporting person no longer beneficially owns, directly or indirectly, any shares of Cadence common stock. F2: Shares of Class A Common Stock held by WBH 2007 Revocable Trust and a grantor retained annuity trust. |
Filing footnotes · ownership attribution and instrument terms
F1: Disposed of in connection with the Agreement and Plan of Merger by and between BancorpSouth Bank ("BXS") and Cadence Bancorporation ("Cadence"), dated April 12, 2021 and amended as of May of 27, 2021 (the "Merger Agreement"), pursuant to which Cadence was merged with and into BXS, effective October 29, 2021 (the "Merger"). Pursuant to the Merger, each issued and outstanding share of Cadence common stock par value $0.01 was converted into the right to receive .70 shares of the BXS's common stock par value $2.50 per share ("the Exchange Ratio"), subject to cash in lieu of fractional shares. The opening price of the BXS's common stock on the New York Stock Exchange on the effective date of the Merger was $29.16. As a result of the Merger, the reporting person no longer beneficially owns, directly or indirectly, any shares of Cadence common stock.
F2: Shares of Class A Common Stock held by WBH 2007 Revocable Trust and a grantor retained annuity trust.
JPMORGAN CHASE & CO
Report date December 31, 2006 · Filed January 03, 2007
Section 16 reporting ended · disclosed 2007-01-03. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 1,173,569.2154 |
Reported balance
After 2006-12-31 transaction · row 1
1 source rowRow 1 · 2006-12-31 · Tax withholding · Disposed 30,277 · Balance 1,173,569.2154 |
| Common StockSEC Table I · non-derivative | IndirectBy 401(k) | 18,466.23 |
Reported balance
Holding disclosure · report date 2006-12-31 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 18,466.23 |
| Common StockSEC Table I · non-derivative | IndirectBy GRAT | 263,160 |
Reported balance
Holding disclosure · report date 2006-12-31 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 263,160 |
| Common StockSEC Table I · non-derivative | IndirectBy Spouse | 23,253 |
Reported balance
Holding disclosure · report date 2006-12-31 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 23,253 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 27, 2011 Filed May 31, 2011 14:44 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantPhantom Stock · Derivative | 4,142.5021 | $36.21 | $150,000.00 |
DisclosureSEC source: 0001225208-11-015336 · doc4.xml · derivative · entry 2 HARRISON WILLIAM B JR · CIK 0001179576 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,789.7362 Underlying: Common Stock · 4,142.5021 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| March 31, 2011 Filed Apr 1, 2011 12:59 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantPhantom Stock · Derivative | 1,098.1521 | $33.01 | $36,250.00 |
DisclosureSEC source: 0001225208-11-010580 · doc4.xml · derivative · entry 2 HARRISON WILLIAM B JR · CIK 0001179576 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,257.7751 Underlying: Common Stock · 1,098.1521 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| December 31, 2010 Filed Jan 3, 2011 17:51 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantPhantom Stock · Derivative | 825.4717 | $36.04 | $29,750.00 |
DisclosureSEC source: 0001225208-11-000082 · doc4.xml · derivative · entry 2 HARRISON WILLIAM B JR · CIK 0001179576 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,823.8959 Underlying: Common Stock · 825.4717 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| September 30, 2010 Filed Oct 1, 2010 21:05 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantPhantom Stock · Derivative | 930.4537 | $36.81 | $34,250.00 |
DisclosureSEC source: 0001225208-10-021735 · doc4.xml · derivative · entry 2 HARRISON WILLIAM B JR · CIK 0001179576 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,669.8772 Underlying: Common Stock · 930.4537 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| August 04, 2010 Filed Aug 6, 2010 14:51 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantStock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $35.19 | $0.00 |
DisclosureSEC source: 0001225208-10-018700 · doc4.xml · derivative · entry 2 HARRISON WILLIAM B JR · CIK 0001179576 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2020-08-03 F1 · derivative.exercise_date: The option vests in three equal annual installments beginning August 4, 2011. Read SEC document |
| June 30, 2010 Filed Jul 1, 2010 18:12 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantPhantom Stock · Derivative | 641.0066 | $34.97 | $22,416.00 |
DisclosureSEC source: 0001225208-10-015974 · doc4.xml · derivative · entry 2 HARRISON WILLIAM B JR · CIK 0001179576 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,413.3365 Underlying: Common Stock · 641.0066 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 28, 2010 Filed Jun 1, 2010 19:57 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantPhantom Stock · Derivative | 1,632.5319 | $33.69 | $55,000.00 |
DisclosureSEC source: 0001225208-10-014282 · doc4.xml · derivative · entry 2 HARRISON WILLIAM B JR · CIK 0001179576 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,772.3299 Underlying: Common Stock · 1,632.5319 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| March 31, 2010 Filed Apr 2, 2010 16:13 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantPhantom Stock · Derivative | 722.8916 | $37.35 | $27,000.00 |
DisclosureSEC source: 0001225208-10-009541 · doc4.xml · derivative · entry 2 HARRISON WILLIAM B JR · CIK 0001179576 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,849.2855 Underlying: Common Stock · 722.8916 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| December 31, 2009 Filed Jan 4, 2010 19:42 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantPhantom Stock · Derivative | 779.9672 | $36.54 Strike: $0.00 | $28,500.00 |
DisclosureSEC source: 0001225208-10-000140 · doc4.xml · derivative · entry 2 HARRISON WILLIAM B JR · CIK 0001179576 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,853.5039 Underlying: Common Stock · 779.9672 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 02:34 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantStock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $24.30 | $0.00 |
DisclosureSEC source: 0001225208-09-021803 · doc4.xml · derivative · entry 12 HARRISON WILLIAM B JR · CIK 0001179576 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2019-04-30 F3 · price: This option, which vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 02:34 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantStock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $38.04 | $0.00 |
DisclosureSEC source: 0001225208-09-021803 · doc4.xml · derivative · entry 11 HARRISON WILLIAM B JR · CIK 0001179576 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2018-04-29 F3 · price: This option, which vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 02:34 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantStock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $51.86 | $0.00 |
DisclosureSEC source: 0001225208-09-021803 · doc4.xml · derivative · entry 10 HARRISON WILLIAM B JR · CIK 0001179576 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2017-04-26 F3 · price: This option, which vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 02:34 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantStock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $34.44 | $0.00 |
DisclosureSEC source: 0001225208-09-021803 · doc4.xml · derivative · entry 9 HARRISON WILLIAM B JR · CIK 0001179576 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2016-04-27 F3 · price: This option, which vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 02:34 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantStock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $33.83 | $0.00 |
DisclosureSEC source: 0001225208-09-021803 · doc4.xml · derivative · entry 8 HARRISON WILLIAM B JR · CIK 0001179576 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2015-04-28 F3 · price: This option, which vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 02:34 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantStock Option (right to buy) · Derivative | 5,275 | $0.00 Strike: $71.30 | $0.00 |
DisclosureSEC source: 0001225208-09-021803 · doc4.xml · derivative · entry 7 HARRISON WILLIAM B JR · CIK 0001179576 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,275 Underlying: Common Stock · 5,275 shares Expires 2011-04-26 F4 · price: This option, which vesting on the exercisable date, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 02:34 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantStock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $47.23 | $0.00 |
DisclosureSEC source: 0001225208-09-021803 · doc4.xml · derivative · entry 6 HARRISON WILLIAM B JR · CIK 0001179576 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2014-04-29 F3 · price: This option, which vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 02:34 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantStock Option (right to buy) · Derivative | 5,275 | $0.00 Strike: $65.88 | $0.00 |
DisclosureSEC source: 0001225208-09-021803 · doc4.xml · derivative · entry 5 HARRISON WILLIAM B JR · CIK 0001179576 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,275 Underlying: Common Stock · 5,275 shares Expires 2010-04-27 F4 · price: This option, which vesting on the exercisable date, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 02:34 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantStock Option (right to buy) · Derivative | 5,275 | $0.00 Strike: $53.84 | $0.00 |
DisclosureSEC source: 0001225208-09-021803 · doc4.xml · derivative · entry 4 HARRISON WILLIAM B JR · CIK 0001179576 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,275 Underlying: Common Stock · 5,275 shares Expires 2013-04-27 F3 · price: This option, which vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 02:34 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantStock Option (right to buy) · Derivative | 5,275 | $0.00 Strike: $51.60 | $0.00 |
DisclosureSEC source: 0001225208-09-021803 · doc4.xml · derivative · entry 3 HARRISON WILLIAM B JR · CIK 0001179576 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,275 Underlying: Common Stock · 5,275 shares Expires 2012-04-25 F3 · price: This option, which vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 02:34 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantPhantom Stock · Derivative | 27,073.5367 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-09-021803 · doc4.xml · derivative · entry 2 HARRISON WILLIAM B JR · CIK 0001179576 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,073.5367 Underlying: Common Stock · 27,073.5367 shares Expires not disclosed F2 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of Merck & Co., Inc. Common Stock, pursuant to the Plan for Deferred Payment of Directors Compensation, and was exchanged for an equal number of shares of phantom stock of MSD in connection with the Transactions. F2 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of Merck & Co., Inc. Common Stock, pursuant to the Plan for Deferred Payment of Directors Compensation, and was exchanged for an equal number of shares of phantom stock of MSD in connection with the Transactions. F2 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of Merck & Co., Inc. Common Stock, pursuant to the Plan for Deferred Payment of Directors Compensation, and was exchanged for an equal number of shares of phantom stock of MSD in connection with the Transactions. Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 02:34 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantCommon Stock | 1,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-09-021803 · doc4.xml · nonDerivative · entry 1 HARRISON WILLIAM B JR · CIK 0001179576 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,400 F1 · price: Received in exchange for an equivalent number of shares of Merck Sharp & Dohme Corp. (formerly Merck & Co., Inc.) ("MSD") common stock in connection with the completion of transactions contemplated by the Agreement and Plan of Merger by and among, inter alia, MSD and Merck & Co., Inc. (formerly Schering-Plough Corporation) (the "Transactions"). Read SEC document |
| December 31, 2006 Filed Jan 3, 2007 14:14 UTC | JPMORGAN CHASE & CO JPM · Entity 2795 | Tax withholdingCommon Stock | 30,277 | $48.58 | $1,470,856.66 |
DisclosureSEC source: 0000019617-07-000004 · har925.xml · nonDerivative · entry 1 HARRISON WILLIAM B JR · CIK 0001179576 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,173,569.2154 Read SEC document |
| October 13, 2006 Filed Oct 16, 2006 17:42 UTC | JPMORGAN CHASE & CO JPM · Entity 2795 | Exercise / conversionStock Options (Rights to Buy) · Derivative | 100,000 | $0.00 Strike: $30.77 | $0.00 |
DisclosureSEC source: 0000019617-06-000528 · har904.xml · derivative · entry 6 HARRISON WILLIAM B JR · CIK 0001179576 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,000 Underlying: Common Stock · 100,000 shares Expires 2007-01-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Option exercised pursuant to 10b5-1 plan dated August 7, 2006 F2 · derivative.exercise_date: Vested annually in thirds beginning on January 21,1998. Read SEC document |
| October 13, 2006 Filed Oct 16, 2006 17:42 UTC | JPMORGAN CHASE & CO JPM · Entity 2795 | Tax withholdingCommon Stock | 79,753 | $48.10 | $3,836,119.30 |
DisclosureSEC source: 0000019617-06-000528 · har904.xml · nonDerivative · entry 2 HARRISON WILLIAM B JR · CIK 0001179576 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,202,968.7679 Read SEC document |
| October 13, 2006 Filed Oct 16, 2006 17:42 UTC | JPMORGAN CHASE & CO JPM · Entity 2795 | Exercise / conversionCommon Stock | 100,000 | $30.77 | $3,077,090.00 |
DisclosureSEC source: 0000019617-06-000528 · har904.xml · nonDerivative · entry 1 HARRISON WILLIAM B JR · CIK 0001179576 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,282,721.7679 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 07, 2006 Filed Aug 8, 2006 15:45 UTC | JPMORGAN CHASE & CO JPM · Entity 2795 | Exercise / conversionStock Options (Rights to Buy) · Derivative | 100,000 | $0.00 Strike: $30.77 | $0.00 |
DisclosureSEC source: 0000019617-06-000442 · har885.xml · derivative · entry 6 HARRISON WILLIAM B JR · CIK 0001179576 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 155,000 Underlying: Common Stock · 100,000 shares Expires 2007-01-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Vested annually in thirds beginning on January 21,1998. Read SEC document |
| August 07, 2006 Filed Aug 8, 2006 15:45 UTC | JPMORGAN CHASE & CO JPM · Entity 2795 | Tax withholdingCommon Stock | 82,158 | $45.09 | $3,704,093.43 |
DisclosureSEC source: 0000019617-06-000442 · har885.xml · nonDerivative · entry 2 HARRISON WILLIAM B JR · CIK 0001179576 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,182,721.7679 Read SEC document |
| August 07, 2006 Filed Aug 8, 2006 15:45 UTC | JPMORGAN CHASE & CO JPM · Entity 2795 | Exercise / conversionCommon Stock | 100,000 | $30.77 | $3,077,090.00 |
DisclosureSEC source: 0000019617-06-000442 · har885.xml · nonDerivative · entry 1 HARRISON WILLIAM B JR · CIK 0001179576 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,264,879.7679 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 25, 2006 Filed Jan 27, 2006 15:50 UTC | JPMORGAN CHASE & CO JPM · Entity 2795 | Tax withholdingCommon Stock | 61,116 | $38.37 | $2,345,020.92 |
DisclosureSEC source: 0000019617-06-000088 · har812.xml · nonDerivative · entry 1 HARRISON WILLIAM B JR · CIK 0001179576 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,161,918.8325 F1 · balance_after: Excludes 263,160 shares previously owned directly which were contributed to a Grantor Retained Annuity Trust on January 23, 2006. Read SEC document |
| January 19, 2006 Filed Jan 20, 2006 17:11 UTC | JPMORGAN CHASE & CO JPM · Entity 2795 | GrantCommon Stock | 321,963 | $0.00 | $0.00 |
DisclosureSEC source: 0000019617-06-000040 · har773.xml · nonDerivative · entry 1 HARRISON WILLIAM B JR · CIK 0001179576 · Director · Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,486,194.8325 F1 · kind: This award of restricted stock units will vest 50% on January 25, 2008 and 50% on January 25, 2009. All other award terms are substantially the same as those of the restricted stock units granted on January 20, 2005. Read SEC document |
| November 14, 2005 Filed Nov 16, 2005 15:53 UTC | JPMORGAN CHASE & CO JPM · Entity 2795 | Exercise / conversionStock Options (Rights to Buy) · Derivative | 125,000 | $0.00 Strike: $19.19 | $0.00 |
DisclosureSEC source: 0000019617-05-000590 · har736.xml · derivative · entry 5 HARRISON WILLIAM B JR · CIK 0001179576 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 125,000 shares Expires 2006-01-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Option exercised pursuant to 10b5-1 plan dated October 20, 2005. F2 · derivative.exercise_date: Vested annually in thirds beginning on January 16, 1997. Read SEC document |
| November 14, 2005 Filed Nov 16, 2005 15:53 UTC | JPMORGAN CHASE & CO JPM · Entity 2795 | Tax withholdingCommon Stock | 90,656 | $38.10 | $3,453,993.60 |
DisclosureSEC source: 0000019617-05-000590 · har736.xml · nonDerivative · entry 2 HARRISON WILLIAM B JR · CIK 0001179576 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,164,231.8325 Read SEC document |
| November 14, 2005 Filed Nov 16, 2005 15:53 UTC | JPMORGAN CHASE & CO JPM · Entity 2795 | Exercise / conversionCommon Stock | 125,000 | $19.19 | $2,398,437.50 |
DisclosureSEC source: 0000019617-05-000590 · har736.xml · nonDerivative · entry 1 HARRISON WILLIAM B JR · CIK 0001179576 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,254,887.8325 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 03, 2005 Filed Nov 4, 2005 16:17 UTC | JPMORGAN CHASE & CO JPM · Entity 2795 | Exercise / conversionStock Options (Rights to Buy) · Derivative | 100,000 | $0.00 Strike: $19.19 | $0.00 |
DisclosureSEC source: 0000019617-05-000583 · har735.xml · derivative · entry 5 HARRISON WILLIAM B JR · CIK 0001179576 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,000 Underlying: Common Stock · 100,000 shares Expires 2006-01-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Vested annually in thirds beginning on January 16, 1997. Read SEC document |
| November 03, 2005 Filed Nov 4, 2005 16:17 UTC | JPMORGAN CHASE & CO JPM · Entity 2795 | Tax withholdingCommon Stock | 73,172 | $37.24 | $2,724,559.42 |
DisclosureSEC source: 0000019617-05-000583 · har735.xml · nonDerivative · entry 2 HARRISON WILLIAM B JR · CIK 0001179576 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,129,887.8325 Read SEC document |
| November 03, 2005 Filed Nov 4, 2005 16:17 UTC | JPMORGAN CHASE & CO JPM · Entity 2795 | Exercise / conversionCommon Stock | 100,000 | $19.19 | $1,918,750.00 |
DisclosureSEC source: 0000019617-05-000583 · har735.xml · nonDerivative · entry 1 HARRISON WILLIAM B JR · CIK 0001179576 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,203,059.8325 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 17, 2005 Filed Jun 21, 2005 10:11 UTC | JPMORGAN CHASE & CO JPM · Entity 2795 | Exercise / conversionStock Options (Rights to Buy) · Derivative | 225,000 | $0.00 Strike: $15.77 | $0.00 |
DisclosureSEC source: 0000019617-05-000415 · har665.xml · derivative · entry 5 HARRISON WILLIAM B JR · CIK 0001179576 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 225,000 shares Expires 2005-06-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Option exercised pursuant to 10b5-1(c) plan dated February 10, 2005. F2 · derivative.exercise_date: Vested annually in thirds beginning on June 20, 1996. Read SEC document |
| June 17, 2005 Filed Jun 21, 2005 10:11 UTC | JPMORGAN CHASE & CO JPM · Entity 2795 | Tax withholdingCommon Stock | 154,959 | $36.04 | $5,584,722.36 |
DisclosureSEC source: 0000019617-05-000415 · har665.xml · nonDerivative · entry 2 HARRISON WILLIAM B JR · CIK 0001179576 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,100,724.5673 Read SEC document |
| June 17, 2005 Filed Jun 21, 2005 10:11 UTC | JPMORGAN CHASE & CO JPM · Entity 2795 | Exercise / conversionCommon Stock | 225,000 | $15.77 | $3,548,452.50 |
DisclosureSEC source: 0000019617-05-000415 · har665.xml · nonDerivative · entry 1 HARRISON WILLIAM B JR · CIK 0001179576 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,255,683.5673 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 25, 2005 Filed Jan 26, 2005 14:28 UTC | JPMORGAN CHASE & CO JPM · Entity 2795 | Tax withholdingCommon Stock | 31,876 | $37.02 | $1,180,049.52 |
DisclosureSEC source: 0000019617-05-000093 · har629.xml · nonDerivative · entry 1 HARRISON WILLIAM B JR · CIK 0001179576 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,028,496.0943 Read SEC document |
| January 20, 2005 Filed Jan 24, 2005 15:56 UTC | JPMORGAN CHASE & CO JPM · Entity 2795 | GrantStock Appreciation Right · Derivative | 600,481 | $0.00 Strike: $37.47 | $0.00 |
DisclosureSEC source: 0000019617-05-000050 · har591.xml · derivative · entry 1 HARRISON WILLIAM B JR · CIK 0001179576 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 600,481 Underlying: Common Stock · 600,481 shares Expires 2015-01-20 F1 · derivative.exercise_date: Vests in two equal annual installments beginning January 25, 2007. Read SEC document |
| March 08, 2004 Filed Mar 9, 2004 16:21 UTC | JPMORGAN CHASE & CO JPM · Entity 2795 | Exercise / conversionStock Options (Rights to Buy) · Derivative | 225,000 | $0.00 Strike: $12.98 | $0.00 |
DisclosureSEC source: 0000019617-04-000196 · har420.xml · derivative · entry 5 HARRISON WILLIAM B JR · CIK 0001179576 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 225,000 shares Expires 2004-06-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Option exercise pursuant to 10b5-1(c) plan dated November 14, 2003. F2 · derivative.exercise_date: Vested annually in thirds beginning on June 21, 1995. Read SEC document |
| March 08, 2004 Filed Mar 9, 2004 16:21 UTC | JPMORGAN CHASE & CO JPM · Entity 2795 | Tax withholdingCommon Stock | 122,134 | $43.21 | $5,276,799.47 |
DisclosureSEC source: 0000019617-04-000196 · har420.xml · nonDerivative · entry 2 HARRISON WILLIAM B JR · CIK 0001179576 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,057,470.6766 Read SEC document |
| March 08, 2004 Filed Mar 9, 2004 16:21 UTC | JPMORGAN CHASE & CO JPM · Entity 2795 | Exercise / conversionCommon Stock | 225,000 | $12.98 | $2,920,320.00 |
DisclosureSEC source: 0000019617-04-000196 · har420.xml · nonDerivative · entry 1 HARRISON WILLIAM B JR · CIK 0001179576 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,179,604.6766 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 11, 2004 Filed Feb 13, 2004 14:55 UTC | JPMORGAN CHASE & CO JPM · Entity 2795 | GrantStock Appreciation Right · Derivative | 427,928 | $0.00 Strike: $39.96 | $0.00 |
DisclosureSEC source: 0000019617-04-000146 · har387.xml · derivative · entry 2 HARRISON WILLIAM B JR · CIK 0001179576 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 427,928 Underlying: Common Stock · 427,928 shares Expires 2014-02-11 F1 · derivative.exercise_date: Vests in two equal annual installments beginning January 25, 2006. Read SEC document |
| February 11, 2004 Filed Feb 13, 2004 14:55 UTC | JPMORGAN CHASE & CO JPM · Entity 2795 | GrantCommon Stock | 142,643 | $0.00 | $0.00 |
DisclosureSEC source: 0000019617-04-000146 · har387.xml · nonDerivative · entry 1 HARRISON WILLIAM B JR · CIK 0001179576 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 953,572.776 Read SEC document |
| January 25, 2004 Filed Jan 27, 2004 11:33 UTC | JPMORGAN CHASE & CO JPM · Entity 2795 | Tax withholdingCommon Stock | 15,078 | $39.83 | $600,556.74 |
DisclosureSEC source: 0000019617-04-000044 · har362.xml · nonDerivative · entry 1 HARRISON WILLIAM B JR · CIK 0001179576 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 810,929.776 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.